About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Brain Cancer Clinical Trials in Boston | 158 Studies

Clinical Trials Brain CancerBoston

Brain Cancer Clinical Trials in Boston

Find 158 clinical trials for brain cancer near Boston, Massachusetts. Connect with research centers in your area.

All Brain Cancer trials nationwide All trials in Boston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 61-80 of 158 trials

CompletedGefitinib Plus Temozolomide in Treating Patients With Malignant Primary GliomaRATIONALE: Biological therapies such as gefitinib may interfere with the growth of cancer cells and slow the growth of the tumor.NCT00027625·Los Angeles, California and 10 others CompletedRadiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain TumorsRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Giving radiation therapy in different ways may kill more tumor cells.NCT00003574·Birmingham, Alabama and 8 others

Brain Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedKarenitecin in Treating Patients With Recurrent Malignant GliomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00014521·Birmingham, Alabama and 7 others

CompletedCombination Chemotherapy Plus Gene Therapy in Treating Patients With CNS TumorsRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00005796·Indianapolis, Indiana and 1 other

TerminatedA Phase 2 Study of PLX3397 in Patients With Recurrent GlioblastomaThe objective of this study is to evaluate the response of subjects with recurrent glioblastoma to continuous therapy of PLX3397.NCT01349036·Los Angeles, California and 5 others

CompletedAdult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade GliomasThis study was conducted to evaluate the efficacy and safety of depatuxizumab mafodotin (ABT-414) alone or with temozolomide versus temozolomide or lomustine alone in adult…NCT02343406·Palo Alto, California and 101 others

CompletedEffect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)The study is a randomized, controlled trial, designed to test the efficacy and safety of a new medical device, the NovoTTF-100A.NCT00379470·Chicago, Illinois and 24 others

CompletedRisk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed GliomasRATIONALE: Patients with gliomas may be at risk for developing blood clots.NCT00253669·Birmingham, Alabama and 8 others

CompletedLerapolturev in Recurrent Malignant GliomaThis is a phase 2 study of lerapolturev, an oncolytic polio/rhinovirus recombinant, in adult patients with recurrent World Health Organization (WHO) grade IV malignant glioma.NCT02986178·San Francisco, California and 5 others

TerminatedTP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade GliomaRATIONALE: The TP-38 toxin can locate tumor cells and kill them without harming normal cells. Giving TP-38 toxin directly into the tumor may kill more tumor cells.NCT00074334·Washington D.C., District of Columbia and 7 others

CompletedAtrasentan in Treating Patients With Progressive or Recurrent Malignant GliomaRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00017264·Birmingham, Alabama and 9 others

CompletedCCI-779 in Treating Patients With Malignant GliomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00022724·Los Angeles, California and 9 others

CompletedA Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade GliomasDrugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00045708·Atlanta, Georgia and 4 others

CompletedGossypol in Treating Patients With Progressive or Recurrent Glioblastoma MultiformeThis phase II trial is studying how well gossypol works in treating patients with progressive or recurrent glioblastoma multiforme.NCT00540722·Birmingham, Alabama and 7 others

CompletedLapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade GliomaThis pilot phase I clinical trial studies how well lapatinib ditosylate before surgery works in treating patients with high-grade glioma that has come back after a period of time…NCT02101905·Los Angeles, California and 11 others

CompletedA Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) AmplificationThis study seeks to determine whether the addition of ABT-414 to concomitant radiotherapy and temozolomide (TMZ) followed by combination of ABT-414 with adjuvant TMZ prolongs…NCT02573324·Phoenix, Arizona and 211 others

CompletedRadiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma MultiformeRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Chemotherapy uses different ways to stop tumor cells from dividing so they stop growing or die.NCT00002545·Birmingham, Alabama and 259 others

RecruitingG-CSF After Chemo-radiation in Patients With GlioblastomaThis research study involves the study of granulocyte colony stimulating factor (G-CSF) in patients with MGMT-methylated glioblastoma multiforme (GBM) that are undergoing standard…NCT06649851·Boston, Massachusetts

CompletedStudy of Tesevatinib Monotherapy in Patients With Recurrent GlioblastomaThis is a multicenter, Phase 2 study to assess the activity of tesevatinib in patients with recurrent glioblastoma.NCT02844439·Tucson, Arizona and 10 others

CompletedBrachytherapy in Treating Patients With Recurrent Malignant GliomaRATIONALE: Brachytherapy uses radioactive material to kill cancer cells remaining after surgery.NCT00045474·Birmingham, Alabama and 8 others

PreviousPage 4 of 8Next

Other Conditions in Boston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia